Published • loading... • Updated
Ozempic Weight Loss Ads; New Dietary Guidelines; More Type 1.5 Diabetes Diagnoses
Eli Lilly’s oral drug forglipron showed up to 11% weight loss in trials as clinicians report 83% increase in type 1.5 diabetes diagnoses over the past decade.
Summary by MedPage Today
3 Articles
3 Articles
Ozempic Weight Loss Ads; New Dietary Guidelines; More Type 1.5 Diabetes Diagnoses
(MedPage Today) -- Due to sponsored search results -- a form of online advertising -- the Ozempic formulation of semaglutide appears in Google searches for weight loss, despite not being FDA-approved for this indication. (NPR) New analyses...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right0Center3Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium

